DNDN
DNDN Articles
Not many stocks are likely to double. Even well-run companies like Cisco Systems (NASDAQ:CSCO) are not likely to move 2x even with great results. The market caps are already too large and the law of...
Published:
Last Updated:
Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the hopes for its Ipilimumab Pivotal Trials in patients with Advanced...
Published:
Last Updated:
Dendreon (NASDAQ:DNDN) has issued a press release noting that it has completed its target enrollment of 500 patients in phase III IMPACT study of PROVENGE for advanced prostate cancer. It also...
Published:
We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. Earlier this year we covered some strange biotech options activity...
Published:
Last Updated:
Dendreon Corporation (NASDAQ:DNDN) has secured a committed equity financing facility under which it may sell up to $130 million of its registered common stock to Azimuth Opportunity, Ltd. over an...
Published:
Last Updated:
An interesting event happened yesterday in the form of an SEC Filing on Dendreon (NASDAQ:DNDN) that ran the stock. In a fed-filing from yesterday it was disclosed that BNP Paribas Arbitrage SA held...
Published:
Last Updated:
Dendreon (NASDAQ:DNDN) has posted its results. The actual EPS and revenues don’t matter because of the stage of the company. But the company did lower its total expenses to $23.4 million. ...
Published:
Dendreon Corp. (NASDAQ:DNDN) will release earnings next Tuesday, August 7, after the close. The volatility in shares has dried up considerably as shares have only traded above $8.00 or below $7.00...
Published:
There was a bit of an unusual message this morning, and that was an advertisement about Dendreon’s (NASDAQ:DNDN) Provenge in the Sunday edition of The Washington Post. Yet it apparently isn’t...
Published:
Last Updated:
It appears that Dendreon (NASDAQ:DNDN) may be an SEC target now, or at least it is going to get the pleasure of dealing with the SEC for a while. The New York regional office of the Securities and...
Published:
Dendreon (DNDN-NASDAQ) is trading up almost another 2% pre-market after Tuesday options activity had shares up $0.47 to close at $7.70 per share. The shares actually hit as high as $8.30 on...
Published:
Stock Tickers: DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO Many of the recent biotech implosions are always interesting to see if short sellers are getting out of the way or adding pressure. Out...
Published:
Last Updated:
Below are the major short interest positions for stocks traded on Nasdaq for the period ending June 15 compared to comparable numbers for May. Company ...
Published:
Dendreon (DNDN) has seen a lot of the old hyperactive trading volume come out of the stock now that it is post-FDA panel review and post-ASCO. The stock has barely traded 2 million shares so far...
Published:
Stock Tickers: AAPL, YHOO, EBAY, LVLT, DNDN, NYX, AMZN, FWLT, GOOG,DELL, MSFT, INTC, C, RAD, SVNT, CSCO, MO, GS, HAL, DNDN On tonight’s MAD MONEY on CNBC, Jim Cramer featured his 500th show on the...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.